Annual gross profit:
$45.78B+$12.23B(+36.47%)Summary
- As of today (April 15, 2025), PFE annual gross profit is $45.78 billion, with the most recent change of +$12.23 billion (+36.47%) on December 1, 2024.
- During the last 3 years, PFE annual gross profit has fallen by -$4.69 billion (-9.30%).
- PFE annual gross profit is now -30.63% below its all-time high of $65.99 billion, reached on December 31, 2022.
Performance
PFE Gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly gross profit:
$11.86B-$583.00M(-4.69%)Summary
- As of today (April 15, 2025), PFE quarterly gross profit is $11.86 billion, with the most recent change of -$583.00 million (-4.69%) on December 1, 2024.
- Over the past year, PFE quarterly gross profit has stayed the same.
- PFE quarterly gross profit is now -37.91% below its all-time high of $19.09 billion, reached on June 1, 2022.
Performance
PFE quarterly gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM gross profit:
$45.77B+$4.85B(+11.85%)Summary
- As of today (April 15, 2025), PFE TTM gross profit is $45.77 billion, with the most recent change of +$4.85 billion (+11.85%) on December 1, 2024.
- Over the past year, PFE TTM gross profit has stayed the same.
- PFE TTM gross profit is now -31.51% below its all-time high of $66.83 billion, reached on December 31, 2022.
Performance
PFE TTM gross profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
PFE Gross profit Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +36.5% | 0.0% | 0.0% |
3 y3 years | -9.3% | 0.0% | 0.0% |
5 y5 years | +39.3% | 0.0% | 0.0% |
PFE Gross profit Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -30.6% | +36.5% | -37.9% | +180.7% | -31.5% | +40.9% |
5 y | 5-year | -30.6% | +39.3% | -37.9% | +180.7% | -31.5% | +77.1% |
alltime | all time | -30.6% | +1762.7% | -37.9% | +3376.5% | -31.5% | +4309.9% |
Pfizer Gross profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $45.78B(+36.5%) | $11.86B(-4.7%) | $45.77B(+11.8%) |
Sep 2024 | - | $12.44B(+24.6%) | $40.93B(+25.1%) |
Jun 2024 | - | $9.98B(-13.2%) | $32.71B(+0.7%) |
Mar 2024 | - | $11.50B(+64.1%) | $32.50B(-6.1%) |
Dec 2023 | $33.54B(-49.2%) | $7.01B(+65.9%) | $34.60B(-19.7%) |
Sep 2023 | - | $4.22B(-56.8%) | $43.08B(-22.3%) |
Jun 2023 | - | $9.77B(-28.2%) | $55.43B(-14.4%) |
Mar 2023 | - | $13.60B(-12.2%) | $64.75B(-3.1%) |
Dec 2022 | $65.99B(+30.8%) | $15.49B(-6.6%) | $66.83B(+2.1%) |
Sep 2022 | - | $16.57B(-13.2%) | $65.45B(+3.9%) |
Jun 2022 | - | $19.09B(+21.8%) | $62.98B(+12.9%) |
Mar 2022 | - | $15.68B(+11.2%) | $55.78B(+10.5%) |
Dec 2021 | $50.47B(+52.2%) | $14.10B(-0.0%) | $50.47B(+11.9%) |
Sep 2021 | - | $14.10B(+18.5%) | $45.08B(+14.9%) |
Jun 2021 | - | $11.90B(+14.9%) | $39.25B(+10.9%) |
Mar 2021 | - | $10.36B(+18.9%) | $35.38B(+6.7%) |
Dec 2020 | $33.17B(+1.0%) | $8.72B(+5.4%) | $33.17B(+28.3%) |
Sep 2020 | - | $8.27B(+2.9%) | $25.85B(-6.5%) |
Jun 2020 | - | $8.04B(-1.3%) | $27.66B(-8.7%) |
Mar 2020 | - | $8.14B(+481.6%) | $30.31B(-7.7%) |
Dec 2019 | $32.85B(+3.2%) | $1.40B(-86.1%) | $32.85B(+3.3%) |
Sep 2019 | - | $10.08B(-5.7%) | $31.79B(-1.6%) |
Jun 2019 | - | $10.69B(+0.0%) | $32.32B(+0.4%) |
Mar 2019 | - | $10.69B(+3033.4%) | $32.18B(+1.1%) |
Dec 2018 | $31.84B(-22.9%) | $341.00M(-96.8%) | $31.84B(-24.1%) |
Sep 2018 | - | $10.60B(+0.5%) | $41.94B(+0.7%) |
Jun 2018 | - | $10.55B(+2.0%) | $41.66B(+0.8%) |
Mar 2018 | - | $10.34B(-1.0%) | $41.35B(+0.1%) |
Dec 2017 | $41.32B(+2.0%) | $10.45B(+1.2%) | $41.32B(+0.1%) |
Sep 2017 | - | $10.32B(+0.9%) | $41.29B(+0.9%) |
Jun 2017 | - | $10.24B(-0.7%) | $40.92B(+0.6%) |
Mar 2017 | - | $10.31B(-1.0%) | $40.66B(+0.4%) |
Dec 2016 | $40.50B(+3.3%) | $10.42B(+4.6%) | $40.50B(-0.5%) |
Sep 2016 | - | $9.96B(-0.1%) | $40.72B(+0.2%) |
Jun 2016 | - | $9.97B(-1.8%) | $40.63B(+0.7%) |
Mar 2016 | - | $10.15B(-4.5%) | $40.33B(+2.9%) |
Dec 2015 | $39.20B(-2.1%) | $10.64B(+7.8%) | $39.20B(+0.6%) |
Sep 2015 | - | $9.87B(+2.0%) | $38.98B(-0.3%) |
Jun 2015 | - | $9.67B(+7.2%) | $39.11B(-1.6%) |
Mar 2015 | - | $9.03B(-13.3%) | $39.75B(-0.7%) |
Dec 2014 | $40.03B(-4.7%) | $10.42B(+4.2%) | $40.03B(-0.9%) |
Sep 2014 | - | $9.99B(-3.1%) | $40.38B(-0.9%) |
Jun 2014 | - | $10.31B(+10.8%) | $40.74B(-1.0%) |
Mar 2014 | - | $9.31B(-13.5%) | $41.16B(-2.0%) |
Dec 2013 | $42.00B(-6.3%) | $10.76B(+3.9%) | $42.00B(-0.9%) |
Sep 2013 | - | $10.36B(-3.5%) | $42.37B(-0.7%) |
Jun 2013 | - | $10.73B(+5.8%) | $42.66B(-2.0%) |
Mar 2013 | - | $10.15B(-8.9%) | $43.52B(-4.4%) |
Dec 2012 | $44.84B(-7.6%) | $11.14B(+4.6%) | $45.51B(+2.9%) |
Sep 2012 | - | $10.64B(-8.2%) | $44.24B(-5.5%) |
Jun 2012 | - | $11.59B(-4.5%) | $46.80B(-2.7%) |
Mar 2012 | - | $12.14B(+23.0%) | $48.12B(-1.4%) |
Dec 2011 | $48.53B(-3.7%) | $9.87B(-25.3%) | $48.79B(-4.8%) |
Sep 2011 | - | $13.20B(+2.2%) | $51.27B(+2.0%) |
Jun 2011 | - | $12.91B(+0.8%) | $50.28B(-1.1%) |
Mar 2011 | - | $12.81B(+3.7%) | $50.81B(+0.9%) |
Dec 2010 | $50.38B(+22.5%) | $12.35B(+1.2%) | $50.38B(-0.5%) |
Sep 2010 | - | $12.21B(-9.2%) | $50.63B(+4.9%) |
Jun 2010 | - | $13.45B(+8.7%) | $48.26B(+9.6%) |
Mar 2010 | - | $12.37B(-1.8%) | $44.04B(+7.1%) |
Dec 2009 | $41.12B(+2.3%) | $12.60B(+28.2%) | $41.12B(+5.0%) |
Sep 2009 | - | $9.83B(+6.5%) | $39.15B(-0.0%) |
Jun 2009 | - | $9.23B(-2.4%) | $39.17B(-1.5%) |
Mar 2009 | - | $9.46B(-11.0%) | $39.78B(-1.0%) |
Dec 2008 | $40.18B(+8.1%) | $10.63B(+7.9%) | $40.18B(+1.0%) |
Sep 2008 | - | $9.85B(+0.1%) | $39.80B(+6.6%) |
Jun 2008 | - | $9.84B(-0.2%) | $37.32B(+2.4%) |
Mar 2008 | - | $9.86B(-3.7%) | $36.45B(-2.0%) |
Dec 2007 | $37.18B(-8.7%) | $10.24B(+39.0%) | $37.18B(-0.4%) |
Sep 2007 | - | $7.37B(-17.9%) | $37.32B(-7.3%) |
Jun 2007 | - | $8.97B(-15.2%) | $40.27B(-2.4%) |
Mar 2007 | - | $10.59B(+1.9%) | $41.24B(+1.3%) |
Dec 2006 | $40.73B | $10.39B(+0.7%) | $40.73B(-0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2006 | - | $10.32B(+3.7%) | $40.91B(+1.7%) |
Jun 2006 | - | $9.95B(-1.2%) | $40.24B(+0.7%) |
Mar 2006 | - | $10.08B(-4.6%) | $39.98B(-2.0%) |
Dec 2005 | $40.17B(-5.7%) | $10.56B(+9.5%) | $40.81B(+0.9%) |
Sep 2005 | - | $9.65B(-0.4%) | $40.43B(-3.7%) |
Jun 2005 | - | $9.69B(-11.1%) | $41.97B(-1.9%) |
Mar 2005 | - | $10.90B(+7.0%) | $42.80B(+0.5%) |
Dec 2004 | $42.60B(+21.2%) | $10.19B(-9.0%) | $42.59B(-1.2%) |
Sep 2004 | - | $11.19B(+6.4%) | $43.12B(+5.2%) |
Jun 2004 | - | $10.52B(-1.6%) | $40.99B(+6.8%) |
Mar 2004 | - | $10.69B(-0.2%) | $38.39B(+9.2%) |
Dec 2003 | $35.15B(+24.3%) | $10.72B(+18.2%) | $35.16B(+8.0%) |
Sep 2003 | - | $9.06B(+14.4%) | $32.55B(+6.9%) |
Jun 2003 | - | $7.92B(+6.2%) | $30.46B(+5.3%) |
Mar 2003 | - | $7.46B(-8.0%) | $28.93B(+2.3%) |
Dec 2002 | $28.28B(+12.2%) | $8.11B(+16.3%) | $28.28B(+9.2%) |
Sep 2002 | - | $6.97B(+9.0%) | $25.89B(+1.3%) |
Jun 2002 | - | $6.39B(-6.1%) | $25.57B(-0.6%) |
Mar 2002 | - | $6.81B(+18.9%) | $25.71B(+1.5%) |
Dec 2001 | $25.20B(+3.5%) | $5.72B(-13.9%) | $25.33B(-3.6%) |
Sep 2001 | - | $6.65B(+1.7%) | $26.28B(+2.8%) |
Jun 2001 | - | $6.54B(+1.8%) | $25.57B(+2.9%) |
Mar 2001 | - | $6.42B(-3.8%) | $24.84B(+1.0%) |
Dec 2000 | $24.35B(+7.2%) | $6.68B(+12.5%) | $24.59B(+1.8%) |
Sep 2000 | - | $5.94B(+2.2%) | $24.16B(+2.6%) |
Jun 2000 | - | $5.81B(-5.8%) | $23.53B(+1.5%) |
Mar 2000 | - | $6.17B(-1.1%) | $23.18B(+13.0%) |
Dec 1999 | $22.71B(+19.4%) | $6.24B(+17.4%) | $20.52B(-16.5%) |
Sep 1999 | - | $5.32B(-2.5%) | $24.57B(+10.2%) |
Jun 1999 | - | $5.45B(+55.4%) | $22.29B(+12.6%) |
Mar 1999 | - | $3.51B(-65.9%) | $19.80B(+4.2%) |
Dec 1998 | $19.02B(+95.9%) | $10.29B(+239.5%) | $19.00B(+67.3%) |
Sep 1998 | - | $3.03B(+2.4%) | $11.36B(+5.4%) |
Jun 1998 | - | $2.96B(+9.3%) | $10.78B(+4.1%) |
Mar 1998 | - | $2.71B(+2.3%) | $10.35B(+1.4%) |
Dec 1997 | $9.71B(+13.8%) | $2.65B(+8.1%) | $10.21B(+11.1%) |
Sep 1997 | - | $2.45B(-3.2%) | $9.19B(+0.8%) |
Jun 1997 | - | $2.53B(-1.5%) | $9.12B(+3.3%) |
Mar 1997 | - | $2.57B(+57.8%) | $8.83B(+3.5%) |
Dec 1996 | $8.53B(+3.6%) | $1.63B(-31.6%) | $8.53B(-7.1%) |
Sep 1996 | - | $2.38B(+6.1%) | $9.18B(+3.6%) |
Jun 1996 | - | $2.25B(-1.1%) | $8.86B(+3.2%) |
Mar 1996 | - | $2.27B(-0.6%) | $8.59B(+3.7%) |
Dec 1995 | $8.23B(+23.7%) | $2.28B(+10.8%) | $8.28B(+5.8%) |
Sep 1995 | - | $2.06B(+4.8%) | $7.83B(+5.3%) |
Jun 1995 | - | $1.97B(+0.1%) | $7.44B(+6.3%) |
Mar 1995 | - | $1.97B(+7.4%) | $7.00B(+5.2%) |
Dec 1994 | $6.65B(+11.6%) | $1.83B(+9.7%) | $6.65B(+3.9%) |
Sep 1994 | - | $1.67B(+9.2%) | $6.40B(+2.7%) |
Jun 1994 | - | $1.53B(-5.7%) | $6.23B(+2.5%) |
Mar 1994 | - | $1.62B(+2.6%) | $6.08B(+1.9%) |
Dec 1993 | $5.96B(+9.0%) | $1.58B(+5.4%) | $5.96B(+1.6%) |
Sep 1993 | - | $1.50B(+9.1%) | $5.87B(+2.2%) |
Jun 1993 | - | $1.37B(-8.7%) | $5.74B(+2.0%) |
Mar 1993 | - | $1.51B(+1.1%) | $5.63B(+3.0%) |
Dec 1992 | $5.47B(+9.5%) | $1.49B(+8.5%) | $5.47B(+3.7%) |
Sep 1992 | - | $1.37B(+8.6%) | $5.27B(+1.6%) |
Jun 1992 | - | $1.26B(-5.7%) | $5.19B(+1.8%) |
Mar 1992 | - | $1.34B(+3.4%) | $5.10B(+2.2%) |
Dec 1991 | $4.99B(+14.2%) | $1.30B(+0.5%) | $4.99B(+2.2%) |
Sep 1991 | - | $1.29B(+9.9%) | $4.88B(+3.5%) |
Jun 1991 | - | $1.17B(-4.6%) | $4.72B(+3.4%) |
Mar 1991 | - | $1.23B(+3.7%) | $4.57B(+4.4%) |
Dec 1990 | $4.37B(+14.5%) | $1.19B(+5.4%) | $4.37B(+37.3%) |
Sep 1990 | - | $1.13B(+10.6%) | $3.18B(+54.8%) |
Jun 1990 | - | $1.02B(-1.8%) | $2.06B(+98.2%) |
Mar 1990 | - | $1.04B | $1.04B |
Dec 1989 | $3.82B(+7.2%) | - | - |
Dec 1988 | $3.56B(+11.8%) | - | - |
Dec 1987 | $3.18B(+9.7%) | - | - |
Dec 1986 | $2.90B(+11.3%) | - | - |
Dec 1985 | $2.61B(+6.1%) | - | - |
Dec 1984 | $2.46B | - | - |
FAQ
- What is Pfizer annual gross profit?
- What is the all time high annual gross profit for Pfizer?
- What is Pfizer annual gross profit year-on-year change?
- What is Pfizer quarterly gross profit?
- What is the all time high quarterly gross profit for Pfizer?
- What is Pfizer quarterly gross profit year-on-year change?
- What is Pfizer TTM gross profit?
- What is the all time high TTM gross profit for Pfizer?
- What is Pfizer TTM gross profit year-on-year change?
What is Pfizer annual gross profit?
The current annual gross profit of PFE is $45.78B
What is the all time high annual gross profit for Pfizer?
Pfizer all-time high annual gross profit is $65.99B
What is Pfizer annual gross profit year-on-year change?
Over the past year, PFE annual gross profit has changed by +$12.23B (+36.47%)
What is Pfizer quarterly gross profit?
The current quarterly gross profit of PFE is $11.86B
What is the all time high quarterly gross profit for Pfizer?
Pfizer all-time high quarterly gross profit is $19.09B
What is Pfizer quarterly gross profit year-on-year change?
Over the past year, PFE quarterly gross profit has changed by $0.00 (0.00%)
What is Pfizer TTM gross profit?
The current TTM gross profit of PFE is $45.77B
What is the all time high TTM gross profit for Pfizer?
Pfizer all-time high TTM gross profit is $66.83B
What is Pfizer TTM gross profit year-on-year change?
Over the past year, PFE TTM gross profit has changed by $0.00 (0.00%)